About 360biolabs
360biolabs is a company based in Melbourne (Australia) founded in 2015 was acquired by BioAgilytix in August 2021. 360biolabs offers products and services including Pharmacokinetics Assays, Pharmacodynamics Assays, Immunogenicity Assays, Biomarkers Assays, and Vaccines and Infectious Diseases Services. 360biolabs operates in a competitive market with competitors including BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
- Headquarter Melbourne, Australia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
BioAgilytix
(Aug 16, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of 360biolabs
360biolabs offers a comprehensive portfolio of products and services, including Pharmacokinetics Assays, Pharmacodynamics Assays, Immunogenicity Assays, Biomarkers Assays, and Vaccines and Infectious Diseases Services.
Services for measuring drug concentrations in clinical studies.
Assays evaluating drug effects on biological systems.
Testing for immune responses to therapeutic drugs.
Analysis of biomarkers in clinical research studies.
Services for virology and infectious disease testing.
Funding Insights of 360biolabs
Detailed funding history for 360biolabs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in 360biolabs
360biolabs has secured backing from 1 investor. Prominent investors backing the company include BioAgilytix.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
Locked | Locked | Locked |
Investor details for 360biolabs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 360biolabs
Investment portfolio details for 360biolabs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - 360biolabs
Detailed financials for 360biolabs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
360Biolabs Comparisons
Peer comparison for 360biolabs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 360biolabs
360biolabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| Locked | Locked | Locked |
Analytical and quality assurance services are provided for diverse industries.
|
|
| Locked | Locked | Locked |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| Locked | Locked | Locked |
Bioanalytical assays for drug development are developed and validated.
|
|
| Locked | Locked | Locked |
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
|
Detailed competitors of 360biolabs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 360Biolabs
Complete news archive for 360biolabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 360biolabs
360biolabs was founded in 2015.
360biolabs is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.
Alistair Draffan is the current CEO of 360biolabs.
360biolabs was founded in 2015 in Melbourne, Australia, as a contract research organization focused on virology and immunology. Services for drug, vaccine, and diagnostic development are delivered through facilities designated BSL-2 and BSL-3, including quarantine labs. Assays are designed, optimized, and validated by the team. Work with eight virus types, such as Herpes, Hepatitis, Retro, Orthomyxo, and Paramyxo, is supported. IND-enabling and clinical development services are also handled.
360biolabs's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
360biolabs offers Pharmacokinetics Assays, Pharmacodynamics Assays, Immunogenicity Assays, Biomarkers Assays, and Vaccines and Infectious Diseases Services.
360biolabs has 1 investor. Key investors include BioAgilytix.